Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-08-09
2011-08-09
Stucker, Jeffrey (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S009700, C514S007600, C514S010100, C424S093700, C424S093100
Reexamination Certificate
active
07994131
ABSTRACT:
The present invention provides for a method for stimulating the proliferation of pluripotential stem cells in a mammal comprising administration of pregnancy related compounds more particularly human chorionic gonadotropin, leutenizing hormone or prolactin. The present invention further provides for a method of treatment of tissues or organs experiencing cellular damage, injury or disease.
REFERENCES:
patent: 4062942 (1977-12-01), Donini
patent: 5055554 (1991-10-01), Nomura et al.
patent: 5128242 (1992-07-01), Arimura et al.
patent: 5198542 (1993-03-01), Onda et al.
patent: 5208320 (1993-05-01), Kitada et al.
patent: 5326860 (1994-07-01), Onda et al.
patent: 5506107 (1996-04-01), Cunningham et al.
patent: 5547935 (1996-08-01), Mullenbach et al.
patent: 5610138 (1997-03-01), Jacobs
patent: 5614184 (1997-03-01), Sytkowski et al.
patent: 5623050 (1997-04-01), Kitada et al.
patent: 5700781 (1997-12-01), Harris
patent: 5723115 (1998-03-01), Serrero
patent: 5773569 (1998-06-01), Wrighton et al.
patent: 5801147 (1998-09-01), Kitada et al.
patent: 5837460 (1998-11-01), Von Feldt et al.
patent: 5851997 (1998-12-01), Harris
patent: 5885574 (1999-03-01), Elliott
patent: 5980887 (1999-11-01), Isner et al.
patent: 6048971 (2000-04-01), Sytkowski et al.
patent: 6191106 (2001-02-01), Mullenbach et al.
patent: 6242563 (2001-06-01), Dong
patent: 6333031 (2001-12-01), Olsson et al.
patent: 6413952 (2002-07-01), Luengo et al.
patent: 6583109 (2003-06-01), Gallo et al.
patent: 6844315 (2005-01-01), Khan et al.
patent: 7097832 (2006-08-01), Kornowski et al.
patent: 7183251 (2007-02-01), Russo et al.
patent: 2002/0098178 (2002-07-01), Brand
patent: 2003/0060415 (2003-03-01), Hung
patent: 01180833 (1989-07-01), None
patent: 2003339 (1993-11-01), None
patent: WO 96/40231 (1996-12-01), None
patent: WO 97/48729 (1997-12-01), None
patent: 199805353 (1998-02-01), None
patent: WO03018782 (2003-03-01), None
patent: WO03024472 (2003-03-01), None
Definition of pluripotent in the medical dictionary: http://medical-dictionary.thefreedictionary.com/pluripotent; accessed Apr. 15, 2008.
Nomura et al., Endocrinologia Japonica (1988), 35(3), 413-419 (Abstract only provided).
Cai et al., NeuroMolecular Medicine, 2002, vol. 2, p. 233-249.
Nomura et al. Acta Endocrinologica, Oct. 1989;121(4):587-594.
Scaffidi, Boll Soc Ital Biol Sper. Oct. 15, 1966;42(19):1284-1286.
“Ischemic Heart Diseas” (Author unknown), http://www.arupconsult.com/Topics/IHD.html#, Accessed May 20, 2010.
Sugahara et al., PNAS 1995 92 (6)2041-2045.
Al-Hader AA et al., “Neurons from Fetal Rat Brain Contain Functional Luteinizing Hormone/Chorionic Gonadotropin Receptors” 1997, vol. 56, pp. 1071-1076.
Fernandez-Pol, J.A., “Epidermal Growth Factor Receptor of A431 Cells”, J Biol Chem, Apr. 1985, vol. 260, No. 8, pp. 5003-5011.
Johnson, D.L. & Jolliffe L.K., “Erythropoietin mimetic peptides and the future”, Nephrol Dial Transplant, 2000, vol. 15, pp. 1274-1277.
Karbanova et al., “Neural Stem Cells Transplanted into Intact Brains As Neurospheres Form Solid Grafts Composed of Neurons, Astrocytes and Oligodendrocyte Precursors”, Biomed. Papers, 2004, vol. 148, No. 2, pp. 217-220.
Kaushanksy, K., “Hematopoietic Growth Factor Mimetics” Ann NY Acad Sci, 2001, vol. 938, pp. 131-138.
Livnah., et al., “Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8A”, Science, Jul. 1996, vol. 273, No. 5274, pp. 464-471.
Mode, A. et al, “The Human Growth Hormone (hGH) AntagonistG120RhGH Does Not Antagonize GH in the Rat, But Has Paradoxical Agonist Activity, Probably Via the Prolactin Receptor*”, Endocrinology, 1996, vol. 137, No. 2, pp. 447-454.
Moro et al, “Maxadilan, the Vasodilator from Sand Flies, Is a Specific Pituitary Adenylate Cyclase Activating Peptide Type I Receptor Agonist*”, J Bio Chem, Jan. 1997, vol. 272, No. 2, pp. 966-970.
Ogueta S. et al., “Prolactin is a Component of the Human Synovial Liquid and Modulates the Growth and Chondrogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells”, Molecular and Cellular Endocrinology 2002, vol. 190, pp. 51-63.
Rodriguez-Pena A., “Oligodendrocyte Development and Thyroid Hormone”, J Neurobiol, 1999, vol. 40, pp. 497-512.
Shingo T. et al., “Pregnancy-Stimulated Neurogenesis in the Adult Female Forebrain Mediated by Prolactin”, Science, Jan. 2003, vol. 299, pp. 117-120.
Wrighton, N.C., et al., “Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin”, Science, Jul. 1996, vol. 273, No. 5274, pp. 458-463.
DeVito, W.J., et al. “Prolactin-Stimulated Mitogenesis of Cultured Astrocytes*,”Endocrinology130(5): 2549-2556 (1992).
English translation of RU 2003339 C1. Russian Federation Committee for Patents and Trademarks. Published Nov. 30, 1993.
English Translation of Bondarenko, P., “Chorionic Gonadotropin in Treatment of Chronic Circulatory Failure in Patients with Ischemic Heart Disease”, Vrach Delo. 1984, vol. 7, pp. 75-78.
Urbanek et al., “Stem cell niches in the adult mouse heart”, PNAS, Jun. 13, 2006, V. 103, pp. 9226-9231.
Gage, Fred H. and Verman, Inder M. “Stem cells at the dawn of the 21st century,” PNAS vol. 100, sup 1: 11817-11818, Sep. 30, 2003.
Thorne, Rick F. et al. “The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events,” Journal of Cell Science 117: 373-380, 2004.
Watt, Fiona M. and Hogan, Brigid L.M. “Out of Eden: Stem Cells and Their Niches,” Science vol. 287: 1427-1430, Feb. 25, 2000.
XP-002587374 Definition of “Stem Cell” from Wikipedia. Retrieved from “http://web.archive.org/web/20040924012115/http://en.wikipedia.org/wiki/Stem—cell” Printed Jun. 16, 2010.
Abstract of DE19905961 Al, “Use of estrogens to treat cardiac insufficiency and left ventricular dysfunction following myocardial infarction,” Aug. 17, 2000.
Database EPODOC European Patent Office, The Hague, NL; Jul. 18, 1998, XP002626863, Database accession No. JP1180833 abstract & JP 1 180833 A (Nippon Kayaku KK) Jul. 18, 1989.
Partial European Search Report in related European Application No. 11000912.3-1521. Apr. 12, 2011.
Gamett Daniel C
McKeon Meunier Carlin Curfman
Stem Cell Therapeutics Corp.
Stucker Jeffrey
LandOfFree
Stimulation of proliferation of pluripotential stem cells... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stimulation of proliferation of pluripotential stem cells..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stimulation of proliferation of pluripotential stem cells... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2709009